Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 59.41K | $ 620.63K | $ 472.73K | $ 743.50K | $ 622.86K |
Total Assets | $ 901.54K | $ 1.38M | $ 1.36M | $ 1.51M | $ 1.30M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 96.09K | $ 126.94K | $ 92.84K | $ 65.13K | $ 486.19K |
Stockholders Equity | $ 805.45K | $ 1.25M | $ 1.27M | $ 1.44M | $ 809.68K |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |